COMPANY PROFILE -BioNTech SE
Business Sector :Biotechnology
Operating Geography :Germany, Europe, Global
About BioNTech SE :
BioNTech SE is a German biotechnology firm headquartered in Mainz, that develops and manufactures active immunotherapies for patient-specific illness therapy. It creates drug candidates based on messenger ribonucleic acid (mRNA) for use as individualised cancer immunotherapies, vaccines against infectious diseases, and protein replacement therapies for rare diseases, as well as engineered cell therapy, novel antibodies, and small molecule immunomodulators as cancer treatment options. In 2008, Uur Ahin, Zlem Türeci, and Christoph Huber created BioNTech. The business's efforts revolve around the research and manufacture of technology and pharmaceuticals for personalised cancer immunotherapy. The company has over 20 product candidates in development, eight in nine current clinical trials, and has treated over 250 patients with 17 different tumour types. With Pfizer and Fosun, the company is working on “Project Lightspeed” a project to create a revolutionary mRNA technology for a COVID-19 vaccine. On May 28, 2021, Pfizer and BioNTech received the first European Union approval for the COVID-19 vaccine in adolescents.
BioNTech's Unique Selling Point or USP lies in its technology, which allows it to combine modes of action in a coordinated manner to cure cancer more effectively than currently available medications. Because of its synergistic platform and manufacturing capabilities, the company is at the forefront of the paradigm shift toward customised immunotherapies. BioNTech's vision statement reads, "We aspire to individualize cancer medicine".
BioNTech SE Revenue :
€ 482.3 million - FY ending 31st December 2020 (y-o-y growth 344%)
€ 108.6 million - FY ending 31st December 2019
Competitive Analysis of BioNTech SE
The SWOT analysis for BioNTech SE is presented below in a matrix followed by the detailed analysis report:
| Strengths | Weaknesses |
1. Strategic collaborations with partners like Pfizer led to growth
2. Long term strategy in the field of immuno-oncology
3. First mover in globally used Covid-19 vaccine
4. Strong immuno-engineering competencies
| 1. Lack of sales and marketing capabilities
2. No other large-scale product commercialized other than Covid-19 vaccine
3. Significant accumulated losses over the years
|
| Opportunities | Threats |
1. mRNA based pharmaceuticals have great potential in healthcare
2. Rapid design and manufacturing capability of strain specific vaccines
3. Upcoming government orders for vaccines from various countries
| 1. Possible enforcement of export authorization schemes by EU
2. Large number of corporations are in competition for vaccine development
|
On purchase the BioNTech SE SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
Detailed SWOT Analysis of BioNTech SE
Strength
1. Strategic collaborations with partners like Pfizer led to growth: BioNTech had never commercialized a product for the mass market before. As a result, they lacked the sales and distribution network required to reach the customers. Pfizer, is one of the world’s leading pharmaceutical companies with robust sales, marketing, and distribution capabilities. So, the partnership has helped BioNTech to develop the product in a very short time and distribute it in the market. BioNTech received lot of appreciation as it was the first one to come up with the vaccine. Originally, the pharma giant planned to produce 1.3 billion doses in 2021, however with surging demand and expansion of production facilities, the number of doses scheduled to be produced is 2.5 billion. BioNTech is responsible for sale in Germany and Turkey whereas Pfizer is responsible for distribution across the world except China.
2. Long term strategy in the field of immuno-oncology: BioNtech’s Covid vaccine has been developed based on mRNA technology. As the market seems to be accepting this technology, it will be further used in the field of immuno-oncology. The firm intends to apply a first-time developed technology to target cancer through inducing the immunity of the patient. The firm has a clearly devised plan for the necessary clinical trials in order to test these therapies in the upcoming years. For instance, use of RiboCytokines is one of the methods that is based on RNA technology. The firm intends to further expand this pipeline of therapies into individualized cancer medicine and cell therapy. Final goal of the firm is to become the immunotherapy powerhouse by investing the proceeds earned from sale of Covid-19 vaccines.
The remaining section under "Strength" is available only in the 'Complete Report' on purchase.
Weakness
This section is available only in the 'Complete Report' on purchase.
Opportunity
This section is available only in the 'Complete Report' on purchase.
Threat
This section is available only in the 'Complete Report' on purchase.
The PESTLE analysis for BioNTech SE is presented below in a table followed by the detailed analysis report.
| Political | Economical |
1. WHO’s Covax program to ensure availability of vaccines across the world
2. Vaccine diplomacy has become a new way of international relations
3. Pressure on governments to make Covid-19 vaccines available for free
4. Governments controlling vaccine raw material supply for domestic use
| 1. Healthcare sector expanded faster than world economy |
| Social | Technological |
1. Development of vaccine during pandemic brought goodwill to the biotech sector
1. Negative perception about the commercialisation of Covid-19 vaccines | 1. Engineered cell therapies for treatment of tumours |
| Legal | Environmental |
1. Pricing control measures hinder the successful commercial launch
2. Full implementation of ACA act in USA affects pharmaceutical financing
| 1. Climate change may accelerate the occurrence of diseases |
On purchase the BioNTech SE SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
Detailed Pestle Analysis of BioNTech SE
Political
This section is available only in the 'Complete Report' on purchase.
Economic
This section is available only in the 'Complete Report' on purchase.
Social
1. Development of vaccine during pandemic brought goodwill to the biotech sector: After the Covid-19 was declared a global pandemic, many organizations in the world started a race for development of vaccines. But vaccine or drug development and trials would take a very long time for a conventional pharmaceutical firm. Only few firms such as BioNTech, AstraZeneca, Serum Institute of India, Oxford Biomedica, Moderna and Bharat Biotech had the capability to rapidly design the vaccines and manufacture them at large scales. As these firms came up with vaccines in the time of crisis, global citizens saw a silver lining in their efforts. Founders of companies like BioNTech were idolized by the people. This will change the tendency of governments towards biotechnology research in the future. In the long run BioNTech will get benefited due to the goodwill it has earned during the pandemic.
The remaining section under "Social" is available only in the 'Complete Report' on purchase.
Technological
This section is available only in the 'Complete Report' on purchase.
Legal
This section is available only in the 'Complete Report' on purchase.
Environmental
This section is available only in the 'Complete Report' on purchase.
Major Competitors :
- Moderna
- AstraZeneca
- Serum Institute of India
- Oxford Biomedica
- Kite Pharma
- Juno Therapeutics
- Seattle Genetics
- Bharat Biotech
On purchase the BioNTech SE SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.
TABLE OF CONTENTS
DELIVERY AND FORMAT
WHY CHOOSE US?
You may also be interested in other analyses of BioNTech SE:
-
| BioNTech SE Porter's Five Forces Analysis |
|
-
| BioNTech SE VRIO Analysis |
|
-
| BioNTech SE Value Chain Analysis |
|
-
| BioNTech SE Covid-19 Impact Analysis |
|
-
-
| BioNTech SE Segmentation, Targeting and Positioning (STP) Analysis |
|
-
| BioNTech SE Ansoff Matrix Analysis |
|
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Company Overview Report
This report is shared in order to give you an idea of what the complete Company Overview Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Competitor Analysis Report
This report is shared in order to give you an idea of what the complete Competitor Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Porter's Five Forces Analysis Report
This report is shared in order to give you an idea of what the complete Porter's Five Forces Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
VRIO Analysis Report
This report is shared in order to give you an idea of what the complete VRIO Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Value Chain Analysis Report
This report is shared in order to give you an idea of what the complete Value Chain Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Regulatory Outlook Report
This report is shared in order to give you an idea of what the complete Regulatory Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Risk Analysis Report
This report is shared in order to give you an idea of what the complete Risk Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key Performance Indicators (KPI's) Report
This report is shared in order to give you an idea of what the complete Key Performance Indicators (KPI's) Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Environmental, Social, and Governance (ESG) Analysis Report
This report is shared in order to give you an idea of what the complete Environmental, Social, and Governance (ESG) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
M&A Analysis Report
This report is shared in order to give you an idea of what the complete M&A Report and Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Subsidiaries, Partnerships and Collaborations Report
This report is shared in order to give you an idea of what the complete Subsidiaries, Partnerships and Collaborations Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Stakeholder Analysis Report
This report is shared in order to give you an idea of what the complete Stakeholder Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Technology Landscape and Outlook Report
This report is shared in order to give you an idea of what the complete Technology Landscape and Outlook Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Covid-19 Impact Analysis Report
This report is shared in order to give you an idea of what the complete Covid-19 Impact Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Key News and Events Report
This report is shared in order to give you an idea of what the complete Key News and Events Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
BCG Analysis Report
This report is shared in order to give you an idea of what the complete BCG Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Digital Marketing and Social Media Strategy Analysis Report
This report is shared in order to give you an idea of what the complete Digital Marketing and Social Media Strategy Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Segmentation, Targeting and Positioning (STP) Analysis Report
This report is shared in order to give you an idea of what the complete Segmentation, Targeting and Positioning (STP) Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Request for Quotation
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Get The Free Sample
Ansoff Matrix Analysis Report
This report is shared in order to give you an idea of what the complete Ansoff Matrix Analysis Report will cover after purchase. We invest deep in order to bring you insightful research which can add tangible value to your business or academic goals, at such affordable pricing.
Get this report delivered straight into your email inbox for free.
You also agree to receive email updates from us on our new reports and solutions.
We do not share your information with anyone. However, we may send you emails on our new reports and solutions.
Check Out Analysis of Other Relevant Companies
References used in BioNTech SE SWOT & PESTLE Analysis Report
1. BioNTech SE (BNTX) Q4 2020 Earnings Call Transcript - https://www.fool.com/earnings/call-transcripts/2021/03/31/biontech-se-bntx-q4-2020-earnings-call-transcript/
2. BioNTech SE Form 20-F - https://investors.biontech.de/static-files/e862a8ea-5d90-4672-acfb-34de57b58806
3. Vaccine Diplomacy: A New Frontier In International Relations - https://www.forbes.com/sites/saibala/2021/02/24/vaccine-diplomacy-a-new-frontier-in-international-relations/?sh=13e58f1222bc
4. The Husband-and-Wife Team Behind the Leading Vaccine to Solve Covid-19 - The New York Times - https://www.nytimes.com/2020/11/10/business/biontech-covid-vaccine.html
5. Engineered Cell Therapies | BioNTech - https://biontech.de/how-we-translate/engineered-cell-therapies
The detailed complete set of references are available on request in the 'Complete report' on purchase.
How to Reference This Page?
You can use the following in your reference section in order to give credit to the source. For different referencing styles and detailed guidelines, please click here.
BioNTech SE SWOT and PESTLE Analysis - SWOT & PESTLE.COM
SWOT & PESTLE.com (2024). BioNTech SE SWOT and PESTLE Analysis - SWOT & PESTLE.com. [online] Available at: https://www.swotandpestle.com/biontech-se/ [Accessed 18 Apr, 2024].
In-text: (SWOT & PESTLE.com, 2024)
Copyrights and Disclaimer
BioNTech SE SWOT and PESTLE analysis has been conducted by Mohit Harishchandra Deshmukh and reviewed by senior analysts from Barakaat Consulting.
Copyright of BioNTech SWOT and PESTLE Analysis is the property of Barakaat Consulting. Please refer to the Terms and Conditions and Disclaimer for usage guidelines.
Safe and secure payments
